Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Plant Sci.

Sec. Plant Pathogen Interactions

Volume 16 - 2025 | doi: 10.3389/fpls.2025.1703682

A pathogen in waiting: Transcriptomics uncovers the lifestyle of Cercospora zeina during its infection of maize (Zea mays L.) and reveals the expression of immune-activating effectors

Provisionally accepted
Trystan  NadasenTrystan Nadasen1*Carla  BuitendagCarla Buitendag1Rodé  VisserRodé Visser1Tanya  WelgemoedTanya Welgemoed1Ingo  HeinIngo Hein2*Dave  Kenneth BergerDave Kenneth Berger1*
  • 1Department of Plant and Soil Sciences, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
  • 2Potato Disease Resistance group, James Hutton Institute, Dundee, United Kingdom

The final, formatted version of the article will be published soon.

Cercospora zeina is a fungal pathogen that causes gray leaf spot (GLS) disease on maize (Zea mays L.) in Africa. Upon landing on a leaf, the pathogen enters through the stomata and continues to develop asymptomatically for up to 28 days before symptoms appear. As previous work has yet to adequately determine how the pathogen behaves during its infective period, we used transcriptomics to gain insights about the in-planta development of the pathogen and explore its use of effectors to facilitate this process. Samples from B73 maize inbreds infected with C. zeina were harvested in a time course experiment and used for deep RNA sequencing. We used reads mapped to the C. zeina genome as a proxy for biomass accumulation. Following the latent period, C. zeina was found to rapidly accumulate biomass and showed a nearly 50-fold increase in biomass as symptoms appeared. Two distinct transcriptional waves occurred across the infection period. The first wave showed expression of genes for cellular growth, maintenance and immune avoidance, whereas the second wave was enriched with genes involved in detoxification and carbohydrate catabolism. A total of 140 putative effector genes were differentially expressed over the time course, with most upregulated during the mid stage when the switch to necrotrophy occurs. Transient expression of three of these C. zeina effectors (CzEcp2, CzNIS1a, CzNIS1b) induced plant immunity in Nicotiana spp. resulting in the development of cell death. The CzNIS1a effector required a signal peptide for activity in Nicotiana benthamiana, indicating that it is most likely secreted into the apoplast for this function. The previously undescribed CzNIS1b family member has an N-terminal domain with high sequence and structural identity to CzNIS1a plus a C-terminal domain made up of four alpha helices. Orthologues of CzNIS1b appear to be limited to the Mycosphaerellaceae. This study suggests that a cohort of C. zeina effectors expressed during the mid-stage of infection have functions for which receptors are present in non-host species like tobacco. Altogether, this work suggests C. zeina behaves as a latent necrotroph and provides a foundation for future research into the infection biology of C. zeina.

Keywords: RNAseq, Gray leaf spot disease, hypersensitive response, Nicotiana, Ecp2, NIS1a

Received: 11 Sep 2025; Accepted: 20 Oct 2025.

Copyright: © 2025 Nadasen, Buitendag, Visser, Welgemoed, Hein and Berger. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Trystan Nadasen, trystan.nadasen@fabi.up.ac.za
Ingo Hein, ingo.hein@hutton.ac.uk
Dave Kenneth Berger, dave.berger@fabi.up.ac.za

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.